methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate has been researched along with capsazepine in 1 studies
Studies (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Trials (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Recent Studies (post-2010) (methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate) | Studies (capsazepine) | Trials (capsazepine) | Recent Studies (post-2010) (capsazepine) |
---|---|---|---|---|---|
16 | 0 | 0 | 781 | 3 | 273 |
Protein | Taxonomy | methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate (IC50) | capsazepine (IC50) |
---|---|---|---|
Transient receptor potential cation channel subfamily V member 1 | Rattus norvegicus (Norway rat) | 0.4293 | |
Transient receptor potential cation channel subfamily V member 1 | Homo sapiens (human) | 0.2587 | |
Transient receptor potential cation channel subfamily V member 4 | Rattus norvegicus (Norway rat) | 0.6333 | |
Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 0.6333 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beckmann, N; Blé, FX; Cannet, C; Fozard, JR; Karmouty-Quintana, H; Page, CP; Zurbruegg, S | 1 |
1 other study(ies) available for methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate and capsazepine
Article | Year |
---|---|
In vivo pharmacological evaluation of compound 48/80-induced airways oedema by MRI.
Topics: Androstadienes; Animals; Anti-Inflammatory Agents; Aza Compounds; Benzamides; Bronchoalveolar Lavage Fluid; Budesonide; Capsaicin; Cell Degranulation; Cromolyn Sodium; Disease Models, Animal; Drug Evaluation, Preclinical; Indomethacin; Lung; Magnetic Resonance Imaging; Male; Mast Cells; Naphthoquinones; ortho-Aminobenzoates; p-Methoxy-N-methylphenethylamine; Proteins; Pulmonary Edema; Rats; Rats, Inbred BN; Respiratory System Agents; Time Factors; Wortmannin | 2008 |